I
Regulatory Media Placements
Coverage in Bloomberg, Politico, the Financial Times, and sector press covering your regulatory environment. We secure editorial placements that place your company in the journalism policymakers actually read.
When regulation is being written, the companies with editorial presence shape the outcome. We build that presence.
Companies navigating regulatory environments need a PR agency that understands policy as well as media. We have placed fintech, healthcare, energy, and technology clients in Bloomberg, Politico, the Financial Times, and the sector publications that policymakers read.
Four deliverables covering regulatory media placements, policy position building, coalition PR, and crisis response.
Coverage in Bloomberg, Politico, the Financial Times, and sector press covering your regulatory environment. We secure editorial placements that place your company in the journalism policymakers actually read.
Establishing your company or association as the credible voice on a specific policy issue. Through op-eds, expert commentary, and bylined articles, we build the editorial record that defines your position in regulatory debate.
Media strategy for industry groups, trade associations, and coalitions seeking regulatory outcomes. We coordinate multi-stakeholder editorial campaigns that amplify the collective position across publications that shape policy.
Rapid narrative management when regulatory action creates reputational or operational risk. We engage the relevant press quickly with a clear, consistent position that limits damage and restores credibility.
We identify the journalists, publications, and policy cycles relevant to your regulatory environment. Understanding which reporters cover your sector, and which policy timelines are active, determines where and when to place your position.
We clarify and articulate your policy position in terms that earn media interest. A position that works in a regulatory comment period rarely works as a Bloomberg headline. We translate between the two without losing the substance.
Targeted engagement with reporters on the regulatory, finance, and technology beats. We approach the journalists who cover your policy environment with tailored pitches tied to active news cycles and pending regulatory decisions.
We build a consistent archive of published positions that regulators and legislators encounter. A company that has appeared across Bloomberg, Politico, and the FT on a policy topic over twelve months has a record that carries weight in any regulatory process.
Policy advocacy PR is the use of earned editorial coverage to build and maintain a company's public position on regulatory or legislative issues. Unlike advocacy advertising, which policymakers recognise as a paid position, editorial placement in Bloomberg, Politico, or the Financial Times carries the credibility of independent journalism. For companies in regulated industries, a consistent presence in these publications is not a communications exercise. It is a strategic asset that shapes how regulators, legislators, and their staff understand your company and its policy position.
Companies in fintech, healthcare, energy, and artificial intelligence face regulatory cycles that are actively reshaping their commercial environment. The rules being written today around open banking, drug pricing, carbon markets, and AI governance will determine which business models thrive and which face compliance costs that undermine them. Companies that have established editorial presence in the publications that regulators and legislators read are positioned to participate in that process through the media record they have built. Companies that have not are subject to an outcome they had no part in shaping.
Regulators, legislators, and their staff read Bloomberg, Politico, the Financial Times, and sector publications such as Healthcare Dive, Utility Dive, and American Banker. These are the publications that brief decision-makers on industry developments, surface expert opinion on proposed rules, and form the documented record of what the industry argued during a regulatory debate. A company that appears consistently as a named source in this coverage has participated in the regulatory conversation. A company absent from it has not, regardless of what it submitted in formal comment periods.
Advocacy advertising, whether in print, digital, or broadcast formats, is understood by audiences as a paid position. It serves awareness goals, but it does not carry the independent verification that editorial coverage provides. A journalist who sought your comment for a Bloomberg story on fintech regulation has implicitly validated your company as a credible source on the topic. That validation is what advertising cannot replicate and what policy advocacy PR is designed to build systematically over a campaign period.
Policy advocacy PR is the practice of using earned media to build a public position on regulatory or legislative issues. Rather than speaking directly to lawmakers, it creates a documented record of your company or industry's stance in the publications that policymakers read.
Fintech and financial services, healthcare and pharma, energy and sustainability, artificial intelligence, and cryptocurrency companies are the most active users of policy advocacy PR, as these sectors face the most active regulatory development globally.
Lobbying involves direct engagement with legislators and their staff. Policy advocacy PR works through the media, creating public visibility for your position that policymakers encounter through journalism rather than private meetings. The two are complementary rather than competing.
Yes. Editorial placement does not require the budget of a lobbying programme. A consistent series of well-placed opinion pieces and expert quotes in the right publications can establish a company as a credible policy voice regardless of its size.
Success is measured by editorial placements in publications that reach policymakers, consistency of message across coverage, and over time by whether your company becomes a named source in regulatory reporting on the relevant issue.